Tag: corporate

Intercede Group Shares Rise on Market Beat Forecast

[ad_1] By Ian Walker Intercede Group shares rose as much as 18% after the company said that it expects to beat fiscal 2024 market forecasts following the award of a new contract, together with its existing order pipeline. Shares at 1425 GMT were up 13.50 pence, or 14.5%, at 106.50 pence having peaked at 110.0 pence earlier in the session. The London-listed cybersecurity company said Wednesday that it has been awarded a license order worth $1.0 million with a new client in the U.S. intelligence community. The client will also pay an annual subscription of $200,000, it said. The company ... Read more

Energy Stocks Could Struggle in 2024. Analysts Still Like These 11.

[ad_1] Energy By Avi Salzman Dec 24, 2023, 3:30 am EST Share Reprints What OPEC giveth, OPEC can also take away. That, in a nutshell, is the problem for most oil stocks heading into 2024. Continue reading this article with a Barron’s subscription. View Options [ad_2] Source link

Buying a Home Could Get Easier, and More Predictions for 2024

[ad_1] Real Estate By Shaina Mishkin Dec 23, 2023, 1:00 am EST Share Reprints Many home buyers no doubt are relieved to see this year’s inhospitable real estate market in their rear view mirrors. Mortgage rates nearly hit 8% as prices remained firm, making purchases the most expensive in decades. A limited selection of existing homes on the market added to the pain. Continue reading this article with a Barron’s subscription. View Options [ad_2] Source link

Ionis, AstraZeneca get FDA approval for rare genetic disease treatment

[ad_1] Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of a rare genetic disease. The FDA approved Wainua, which has generic name eplontersen, for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. Ionis said Wainua would be available in the U.S. in January. Regulatory reviews elsewhere in the world are currently underway. The disease, also known as hAATR, can cause polyneuropathy, a form of nerve damage. The companies said Wainua is the only approved medicine for treating polyneuropathy from hATTR. The approval ... Read more

FDIC Fights Back Against Former First Republic Employees’ Lawsuit

[ad_1] The Federal Deposit Insurance Corporation is fighting back against a lawsuit brought by nearly 170 former employees of First Republic Bank who are seeking to recover retirement funds they had deposited in a trust set up by the failed lender. The FDIC is arguing that the federal court where the lawsuit was filed earlier this month doesn’t have the authority to grant the temporary restraining order the plaintiffs are seeking, and even if it did, the plaintiffs have failed to make a compelling argument that they would eventually… [ad_2] Source link

Tesla to give 10% pay raises to hourly workers at its Nevada gigafactory: report

[ad_1] Tesla Inc. will give most hourly workers at its Nevada gigafactory roughly 10% raises starting in January, CNBC reported late Monday. Citing internal materials it obtained, CNBC said most hourly workers’ pay at the Sparks, Nev., battery factory will rise from $20 to $22 an hour at the low end and from $30.65 to $34.50 an hour at the high end. Tesla TSLA, -0.56% did not immediately respond for a request for confirmation or comment. The pay raises may be part of an effort to dampen union support at the facility. The United Auto Workers said last month it ... Read more

Vodafone shares surge after Iliad proposes $11.4 billion merger of Italian units

[ad_1] Vodafone VOD, +5.98% shares surged on Monday after French telecoms company Iliad submitted proposals to merge its Italy operations with the British firm’s own struggling Italian business, in a deal worth €10.45 billion ($11.4 billion). Vodafone Italia will be merged into the new company – dubbed NewCo – as its parent company has struggled to boost the Italian unit’s performance amid a price war in the country’s phone market. Shares in Vodafone surged 7% on Monday, having lost 20% of their value over the previous 12 months. Under the proposals, Iliad, which is majority owned by French billionaire Xavier ... Read more